These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36364772)

  • 21. Determination of Miroestrol and Isomiroestrol From Pueraria mirifica (White Kwao Krua) in Dietary Supplements by LC-MS-MS and LC-Q-Orbitrap/MS.
    Lee JH; Kim JY; Cho SH; Jeong JH; Cho S; Park HJ; Baek SY
    J Chromatogr Sci; 2017 Mar; 55(3):214-221. PubMed ID: 28115391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Pueraria mirifica on vaginal health.
    Manonai J; Chittacharoen A; Theppisai U; Theppisai H
    Menopause; 2007; 14(5):919-24. PubMed ID: 17415017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Miroestrol Quantification in Pueraria mirifica Crude Drugs and Products by Single-Reference UPLC/PDA/MS Using Relative Molar Sensitivities to Kwakhurin.
    Masada S; Hosoe J; Arai R; Demizu Y; Hakamatsuka T; Goda Y; Uchiyama N
    Chem Pharm Bull (Tokyo); 2021 Jun; 69(6):573-580. PubMed ID: 33790074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effects of Pueraria mirifica gel and of placebo gel on the vaginal microenvironment of postmenopausal women with Genitourinary Syndrome of Menopause (GSM).
    Sritonchai C; Manonai J; Sophonsritsuk A; Cherdshewasart W
    Maturitas; 2020 Oct; 140():49-54. PubMed ID: 32972635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview of the phytoestrogen effect on vaginal health and dyspareunia in peri- and post-menopausal women.
    Dizavandi FR; Ghazanfarpour M; Roozbeh N; Kargarfard L; Khadivzadeh T; Dashti S
    Post Reprod Health; 2019 Mar; 25(1):11-20. PubMed ID: 30786797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
    Chandeying V; Sangthawan M
    J Med Assoc Thai; 2007 Sep; 90(9):1720-6. PubMed ID: 17957910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (+)-7-
    Yusakul G; Juengsanguanpornsuk W; Sritularak B; Phaisan S; Juengwatanatrakul T; Putalun W
    Nat Prod Res; 2021 Nov; 35(21):4110-4114. PubMed ID: 32077760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pueraria mirifica, a phytoestrogen-rich herb, prevents bone loss in orchidectomized rats.
    Urasopon N; Hamada Y; Asaoka K; Cherdshewasart W; Malaivijitnond S
    Maturitas; 2007 Mar; 56(3):322-31. PubMed ID: 17101247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pueraria mirifica, phytoestrogen-induced change in synaptophysin expression via estrogen receptor in rat hippocampal neuron.
    Chindewa R; Lapanantasin S; Sanvarinda Y; Chongthammakun S
    J Med Assoc Thai; 2008 Feb; 91(2):208-14. PubMed ID: 18389986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges in the conduct of Thai herbal scientific study: efficacy and safety of phytoestrogen, pueraria mirifica (Kwao Keur Kao), phase I, in the alleviation of climacteric symptoms in perimenopausal women.
    Chandeying V; Lamlertkittikul S
    J Med Assoc Thai; 2007 Jul; 90(7):1274-80. PubMed ID: 17710964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Nationwide Survey of the Attitudes toward the Use of Dietary Supplements among Japanese High-School Students.
    Nishijima C; Kobayashi E; Sato Y; Chiba T
    Nutrients; 2019 Jun; 11(7):. PubMed ID: 31261616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Pueraria mirifica on vaginal artery vascularization in postmenopausal women with genitourinary syndrome of menopause.
    Warinsiriruk P; Tantitham C; Cherdshewasart W; Shobeiri SA; Manonai J
    Maturitas; 2022 Jun; 160():4-10. PubMed ID: 35550707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Prevalence of Dietary Supplement Use Among Elementary, Junior High, and High School Students: A Nationwide Survey in Japan.
    Kobayashi E; Nishijima C; Sato Y; Umegaki K; Chiba T
    Nutrients; 2018 Aug; 10(9):. PubMed ID: 30154316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogenic effects of Pueraria mirifica on the menstrual cycle and hormone-related ovarian functions in cyclic female cynomolgus monkeys.
    Trisomboon H; Malaivijitnond S; Watanabe G; Taya K
    J Pharmacol Sci; 2004 Jan; 94(1):51-9. PubMed ID: 14745118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, Adverse Events, and Factors Associated with Dietary Supplement and Nutritional Supplement Use by US Navy and Marine Corps Personnel.
    Knapik JJ; Trone DW; Austin KG; Steelman RA; Farina EK; Lieberman HR
    J Acad Nutr Diet; 2016 Sep; 116(9):1423-1442. PubMed ID: 27083989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary supplements in a national survey: Prevalence of use and reports of adverse events.
    Timbo BB; Ross MP; McCarthy PV; Lin CT
    J Am Diet Assoc; 2006 Dec; 106(12):1966-74. PubMed ID: 17126626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Pueraria mirifica on vascular function of ovariectomized rabbits.
    Wattanapitayakul SK; Chularojmontri L; Srichirat S
    J Med Assoc Thai; 2005 Jun; 88 Suppl 1():S21-9. PubMed ID: 16862667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pueraria mirifica phytoestrogens improve dyslipidemia in postmenopausal women probably by activating estrogen receptor subtypes.
    Okamura S; Sawada Y; Satoh T; Sakamoto H; Saito Y; Sumino H; Takizawa T; Kogure T; Chaichantipyuth C; Higuchi Y; Ishikawa T; Sakamaki T
    Tohoku J Exp Med; 2008 Dec; 216(4):341-51. PubMed ID: 19060449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the estrogenic activity of the wild Pueraria mirifica by vaginal cornification assay.
    Cherdshewasart W; Kitsamai Y; Malaivijitnond S
    J Reprod Dev; 2007 Apr; 53(2):385-93. PubMed ID: 17229996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nationwide Online Survey to Complement the Current Voluntary Reporting System for Adverse Events Associated with Dietary Supplements: Application to the Case of Skin Manifestations.
    Nishijima C; Sato Y; Chiba T; Umegaki K
    J Nutr Sci Vitaminol (Tokyo); 2018; 64(4):277-283. PubMed ID: 30175791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.